月度归档： 2026 年 2 月

香港, 2026年2月11日 - (亚太商讯 via SeaPRwire.com) - 2月10日，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"或"公司"，股份代号：1788.HK）作为联席保荐人、整体协调人、联席全球协调人、联席全球协调人、联席账簿管理人及联席牵头经办人，成功助力爱芯元智半导体股份有限公司（股票代号：600.HK，简称 "爱芯元智"）于香港交易所主板正式挂牌上市。此次上市丰富了港股在边缘AI推理系统芯片（"SoC"）领域的投资标的，也展现了国泰海通集团在服务半导科技企业方面的综合实力。爱芯元智是AI推理SoC的供货商，专注为边缘计算与终端设备AI应用打造高性能的感知与计算平台，致力于构建先进的AI计算基础设施，推动人工智能普及化。招股文件显示，以2024年出货量计，爱芯元智是全球第一大中高端视觉端侧AI推理芯片提供商，在全球视觉端侧AI推理芯片市场排名前五。爱芯元智的爱芯智眸AI-ISP是全球首个实现规模化商用的AI-ISP解决方案，成为计算机视觉领域一大重要突破。截至2025年9月30日，爱芯元智自成立以来累计交付的SoC已突破1.65亿颗。爱芯元智已独立开发五代SoC并实现商业化，涵盖数十种类型，在视觉终端计算、智能汽车和边缘AI推理应用中已实现大规模生产。此次项目发行最终定价为每股28.2港元，全球发售共10,491.52万股H股，基础发行募集资金规模约29.59亿港元，超额配售权完全行使后总集资额预计约34.02亿港元。国际配售和香港公开发售均获踊跃认购，其中国际配售认购倍数达6.8倍，香港公开发售认购倍数达104.82倍。此次发行获得了来自16名基石投资者的重仓加持，包括豪威集团、雅戈尔、德赛西威及均胜电子等产业资本，以及澳大利亚养老基金NGS Super等国际专业投资方。基石投资者合计认购股份约14.43亿港元，约占本次发售股份的48.76%，充分体现了市场对爱芯元智商业模式及长期发展前景的认可，也为上市后股价稳健提供支撑。该项目的成功彰显了国泰君安国际对人工智能芯片行业的深入理解以及服务高新技术行业的专业能力。未来，国泰海通集团将持续聚焦科技创新领域，充分发挥境内外一体化协同优势，依托全链条金融服务体系，为更多硬科技企业提供从资本运作到战略资源整合的综合赋能，助力其高效链接全球资本市场，共拓智能新时代。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK）,是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高品质、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"A"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的资讯请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BOSTON, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial evaluating ProLectin-M in subjects with laboratory-confirmed acute viral infection. The Bioxyytran Trial reports complete elimination of viral load  in 100% of patients at day 7 versus placebo (p=.001).The completed Phase 2 clinical study was a randomized, double-blind, placebo-controlled, dose-optimization trial evaluating orally administered ProLectin-M in subjects with acute viral infection. The study enrolled 38 subjects, all of whom completed the study. Subjects were randomized to receive one of three ProLectin-M dose levels or a matching placebo, administered over a seven-day treatment period.Viral shedding was assessed using RT-PCR analysis of nasopharyngeal swabs collected at predefined timepoints, with viral clearance defined as non-detection of viral RNA below established PCR thresholds.The study design, endpoints, and duration confirmed Bioxytran’s earlier randomized, placebo-controlled Phase 2 trial, which demonstrated statistically significant reductions in viral load by Day 7, early clearance as soon as Day 3, and no observed viral rebounds during a 14-day post-treatment observation period. The current trial further refined dose selection of four tablets per day and evaluated the reproducibility of rapid viral clearance using the same core virologic assessment methodology.Topline Viral Clearance ResultsFollowing database lock and unblinding, treatment-wise analyses demonstrated the following outcomes:Complete elimination of viral load in 100% of treated subjects by Day 7, compared to the placebo group (p = .001)No viral rebounds observed in the treated population during the 14-day post-treatment observation periodThese results indicate rapid and sustained viral clearance in subjects treated with ProLectin-M.Viral Clearance Timing (All Subjects)Across the full study population:Day 3: 1 of 38 subjects demonstrated non-detection of viral sheddingDay 5: 16 of 38 subjects demonstrated non-detection of viral sheddingDay 7: 38 of 38 subjects demonstrated non-detection of viral sheddingThe study was designed to evaluate viral clearance kinetics and inform dose selection for future late-stage clinical development.“The study design of seven days reflects real-world applications for treating acute viral diseases, with the objective of demonstrating a statistically meaningful reduction in viral load by Day 7,” said Dr. Leslie Ajayi, Chief Medical Officer of Bioxytran. “The results demonstrate that viral clearance occurred more rapidly than anticipated, with a significant proportion of treated subjects achieving viral non-detection by Day 3 and complete clearance by Day 7.”“What continues to distinguish ProLectin-M as a broad-range antiviral drug is its novel mechanism of action,” Dr. Platt continued. “Rather than targeting viral replication inside the cell, our galectin antagonist is designed to interfere with viral entry at the cell surface. This extracellular approach may reduce reliance on immune activation and represents a fundamentally different strategy in antiviral therapy. We believe these results further support the potential of carbohydrate-based therapeutics and the emerging field of Glycovirology.”Next StepsBased on these results, Bioxytran plans to advance regulatory discussions to support late-stage clinical development and evaluate ProLectin-M across additional viral indications consistent with its broad-spectrum antiviral profile.About Bioxytran, Inc.Bioxytran, Inc. is a clinical-stage biotechnology company developing novel carbohydrate-based therapeutics targeting significant unmet medical needs in virology and other disease areas. The Company’s lead program, ProLectin-M, is being developed as a potential broad-spectrum antiviral therapeutic.For more information, please visit www.bioxytraninc.com.Investor & Media Contact:Bryan Feinberg / AmplifiXZephyr@amplifiX.net Company Contact:david.platt@bioxytraninc.com(617) 510-2539Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of applicable federal securities laws, including statements regarding the performance of the technology described herein, the interpretation of clinical trial results, regulatory plans, and future development activities. Forward-looking statements are generally identified by words such as “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” and similar expressions, although not all forward-looking statements include these terms. Such statements are subject to significant risks, uncertainties, and assumptions that could cause actual results to differ materially from those expressed or implied. These risks are described in Bioxytran’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and other filings made from time to time. Bioxytran undertakes no obligation to update or revise any forward-looking statements, except as required under applicable securities laws. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Engagement Strengthens European Investor Outreach as Critical Minerals and Defence Partnerships AccelerateOttawa, Ontario--(ACN Newswire via SeaPRwire.com - February 11, 2026) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a leading developer of high-grade flake graphite deposits and advanced graphite materials for battery, defence, and industrial applications, is pleased to announce that it has engaged Dr. Reuter Investor Relations ("Dr. Reuter") to provide investor awareness and communications services across Germany and the broader European capital markets, effective February 16, 2026.Dr. Reuter is a recognized European investor relations and financial communications firm with an established network of institutional investors, retail shareholders, and financial media throughout the DACH region and the European Union. The engagement is intended to enhance Focus Graphite's visibility among European investors, support market education regarding its vertically integrated graphite strategy, and strengthen shareholder communications as development advances across the Company's flagship projects and downstream processing initiatives. Dr. Reuter's business address is Tower 185, Friedrich-Ebert-Anlage 35-37, 60327 Frankfurt, Germany, and the firm may be contacted at e.reuter@dr-reuter.eu."We are seeing growing strategic and institutional interest from European markets in secure critical minerals supply chains, particularly for battery materials, defence, and advanced industrial applications," said Dean Hanisch, CEO of Focus Graphite. "European stakeholders are increasingly focused on diversifying supply away from highly concentrated sources of graphite. Engaging Dr. Reuter strengthens our ability to communicate directly with German and broader European capital markets, expand institutional awareness, and improve investor access as we advance our resource development and technology initiatives."The engagement comes at a time of accelerating European policy and industrial focus on securing domestic and allied sources of critical raw materials. European governments and industrial stakeholders are increasingly prioritizing supply chain resilience, diversification away from highly concentrated foreign sources, and long-term access to graphite and other materials supporting battery, energy storage, defence, and broader dual-use industrial applications. Initiatives tied to defence readiness and industrial capacity, including frameworks such as the European Union's "ReArm Europe" strategy, are reinforcing demand for secure, traceable, and jurisdictionally aligned graphite supply. The Company believes its high-grade natural graphite resources and downstream processing strategy are well aligned with these evolving European defence and dual-use supply chain priorities.Complementing this engagement, the Company will be participating in the Canadian Critical Minerals Mission to Europe taking place February 16-20, 2026, with scheduled engagements in Rome, Munich, and Paris alongside representatives from Natural Resources Canada and Invest in Canada. The mission is expected to facilitate direct dialogue with government stakeholders, industrial partners, and institutional investors, supporting the advancement of secure transatlantic critical minerals supply chains and expanding strategic relationships across European capital markets and downstream industrial sectors.Under the terms of the agreement, Dr. Reuter will provide investor relations and financial public relations services across European capital markets, including campaign and editorial articles, translation and distribution of press releases, journalist targeting, social media outreach, and ongoing performance reporting. The agreement commences February 16, 2026 and runs for an initial six-month term ending August 16, 2026, at a monthly fee of €4,000. The agreement includes a performance review after three months, at which time the Company may terminate the engagement within seven days without penalty if services are not meeting expectations. Following the initial term, the agreement may be renewed upon mutual consent of both parties. Dr. Reuter is arm's length to the Company and, to the knowledge of the Company, holds no securities of Focus Graphite.About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defence, and advanced materials industries.Our Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining — we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Our commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals — reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc., please visit http://www.focusgraphite.com.LinkedIn: https://www.linkedin.com/company/focus-graphite/ X: https://x.com/focusgraphiteInvestors Contact: Dean Hanisch CEO, Focus Graphite Inc. dhanisch@focusgraphite.com +1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, without limitation: (i) the expected services to be provided by Dr. Reuter Investor Relations pursuant to the investor relations and communications agreement; (ii) the anticipated benefits of the engagement, including increased visibility, investor awareness, and shareholder communications across German and broader European capital markets; (iii) the Company's participation in the Canadian Critical Minerals Mission to Europe, including scheduled engagements in Rome, Munich, and Paris; (iv) the potential outcomes of such engagements, including the development of relationships with government stakeholders, industrial partners, and institutional investors; and (v) the Company's broader strategy to expand its presence and positioning within European critical minerals and advanced materials markets.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283521 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年2月11日 - (亚太商讯 via SeaPRwire.com) - 2月10日，爱芯元智（0600.HK）在港上市，成为中国边缘AI芯片第一股，此次IPO发行价28.2港元，盘中市值超过165亿港元。作为爱芯元智首次对外融资的投资人，联想控股（3396.HK）旗下联想之星也收获了半导体芯片领域首个IPO。不久前，小核酸药物公司瑞博生物（6938.HK）和手术机器人公司精锋医疗（2675.HK）也成功登陆港股。伴随爱芯元智上市的锣声，联想之星开年伊始已见证3家被投企业成功登陆资本市场。这家深耕硬科技十余年的早期投资机构，正迎来属于自己的集中收获季。"祝贺爱芯元智成功上市，凭借智慧城市和智能驾驶双轮驱动，他们已经成长为边端侧AI芯片平台型企业。作为半导体芯片行业为数不多的女性创业者，仇肖莘强大的学习和迭代能力令人印象深刻。"在联想之星总裁、主管合伙人王明耀看来，通过陪伴这家半导体芯片公司从起步到上市，联想之星对半导体芯片的投资逻辑和策略也获得成功验证。联想之星投她 收获首个半导体芯片IPO这是一个投资人与创业者相互成就的故事。时间回到2019年，判断AI在应用层面将迎来爆发后，在半导体行业深耕二十多年的仇肖莘，选择以客户集中度较低但前景同样开阔的边缘侧和端侧AI芯片为切入点，最终创立了爱芯元智。在仇肖莘看来，随着AI与芯片技术的发展，"云边端"三者的结合构成了人工智能的新基建，"通过建设这些基础设施，能够让AI真正地深入到各行各业，然后到普通大众的日常生活中去。"那个时候，系统布局人工智能多年的联想之星，也在长期关注半导体芯片。一个偶然的机会，刚成立不久的爱芯元智进入这家早期投资机构的视野，由此开启了一段投资人长期陪伴创业公司成长的旅程。早在2019年10月，联想之星团队就开始接触爱芯元智。作为中国半导体行业为数不多的女性创业者，仇肖莘首次与联想之星执行董事张琪见面时，这位行业资深老兵便给后者留下极其深刻的印象。"她不仅拥有深厚的技术积淀，还管理过数千人的工程师团队。"一番交流下来，张琪除了近距离感受到仇肖莘平易近人，还发现她对半导体行业有非常深入的认知，"她对AI和半导体产业的深入理解，给了我非常多的启发。"之所以能够深入洞察行业，离不开仇肖莘令人惊艳的职业履历。硕士从清华大学毕业后，她又拿到美国南加州大学电子工程博士学位，并曾先后担任美国AT&T Bell Labs首席科学家、美国博通公司副总裁以及紫光展锐首席技术官等职务。在仇肖莘的带领下，爱芯元智很快组建了从芯片设计、验证、质量控制到供应链管理的全功能团队，核心成员均参与过10颗以上芯片的设计和生产，同时还自研了爱芯智眸AI-ISP和爱芯通元混合精度NPU两大核心技术。"这家公司从一开始就是软硬协同设计，拥有独创性的算法和硬件IP。团队算法know-how与芯片工程化能力相得益彰，突破了端侧AI芯片的设计局限。"据张琪透露，联想之星很快便开始推进对爱芯元智的尽调事宜，最终于2020年3月在线上通过了投资决策。这也意味着，在拿出2000万元投资爱芯元智后，联想之星成为对方首次对外融资的投资人。与此同时，爱芯元智不仅是联想之星第四期基金的首个项目，同时还成为这家早期投资机构当时单笔投资金额最大的人民币项目。在获得联想之星等投资的4个月后，爱芯元智推出了自研的第一代AI芯片。凭借行业首创的"黑光全彩"技术，这款AI芯片能让夜晚拍摄的图片呈现亮如白昼的效果。看到他们出色的表现，联想之星又于2020年10月追投了这家公司1000万元。为了成为一家平台型芯片公司，在智慧城市领域进入收获期后，爱芯元智又于2021年进军智能驾驶，并计划在未来将业务拓展到更广阔的机器人市场。在仇肖莘看来，当产品在不同市场得到验证后，那么就能通过相同的底层技术去持续拓展细分市场。这份多线作战的决心和勇气，让联想之星合伙人高天垚深感佩服，"虽然智能驾驶的市场更加庞大，但同时也需要更大的资金投入，不过爱芯元智在多个业务板块都实现了很好的发展，最终让公司体量得以快速增长。"成立不到3年时间，这家公司便成功研发并量产了两代四颗端侧、边缘侧AI芯片。他们取得的亮眼成绩，也超过了联想之星的预期。没有丝毫犹豫，这家早期投资机构又于2022年1月拿出3000万元支持爱芯元智。在资源对接、产品路线选择及战略制定等方面，联想之星提供的帮助同样让爱芯元智获益匪浅。据仇肖莘透露，双方始终保持紧密沟通，当公司面临一系列决策时，联想之星都能给予有力支持。从大公司的技术高管成功转型为创业公司优秀的创始人，王明耀对仇肖莘强大的学习和迭代能力赞不绝口，"从我们长期的观察来看，如果一个创业项目发展得很好，通常离不开投资人与创始团队之间的良性互动。"一路走来，爱芯元智已构建行业领先的智能计算平台，并全域赋能终端计算、智能汽车、边缘计算、机器人等关键场景，同时驱动边缘侧、端侧人工智能规模化落地与产业升级，芯片累计出货近2亿颗。随着爱芯元智成功上市，联想之星不仅收获了半导体芯片领域和第四期基金的首个IPO，同时还在财务方面获得丰厚回报，为第四期基金良好的业绩表现提供有力支撑。"自上而下"打法 前瞻性系统布局半导体芯片这笔漂亮的投资回报，源于联想之星的精准出手与持续重注。对于联想之星而言，在重投入、长周期、高门槛的半导体芯片行业拥有亮眼的投资命中率，离不开他们的独特基因与长期积累。早在2008年，联想之星在联想控股和中国科学院的支持下成立，旨在发现和培养科技创业人才，孵化科技创业企业，助力科技成果产业化。两年后，他们又做起早期投资，开始系统布局人工智能等前沿科技。得益于"早期投资+深度孵化"的独特模式，联想之星通过"创业CEO特训班"，还有中国科学院体系、国内高校和实验室、产业公司以及海外等渠道，去深入挖掘优质项目，最终成功打造出自己独有的根据地。"以人工智能为切入点，不断拓展在前沿技术领域的投资广度和深度。"在高天垚看来，联想之星通过在各领域形成优质投资组合作为细分根据地，不断增加认知红利和资源积累，最终形成正向循环。沿着这样的投资策略，联想之星在十余年的时间里，持续布局了AI及AI应用、自动驾驶、半导体芯片、机器人/智能机器、商业航天、泛安全、能源科技等前沿科技方向的细分赛道。在不断深入投资前沿科技的过程中，联想之星也在持续加大对人工智能的布局力度，并长期将端侧AI作为重点发力方向。据高天垚介绍，判断人工智能的发展离不开数据的获取与算力的突破后，他们从2015年便开始布局半导体芯片。随着宏观环境发生变化，联想之星发现国产替代与自主可控变得更加重要。再加上下游场景的旺盛需求，意味着中国半导体芯片行业将迎来巨大的发展机遇。"后来决定加大投资力度时，我们还专门召开了一个研讨会。"据王明耀透露，在半导体芯片行业，他们最终形成了"自上而下"的打法。结合自身实际情况，联想之星会通过分析宏观经济、产业政策、技术发展等大趋势，再筛选出半导体芯片行业具有长期增长潜力的方向和环节，最终聚焦于高价值且价格合适的优质标的。"我们在投资半导体芯片时，不是简单地遵循'国产替代'的逻辑，而是会重点关注项目的创新程度。"高天垚直言，在半导体芯片行业，拥有新材料、新技术、新架构、新应用等新要素，才容易获得新的机会。在芯片半导体领域，联想之星通过前瞻性系统布局，在早期阶段，围绕高性能计算投资了爱芯元智、图灵量子、亿铸科技、超摩科技、智傲通；围绕AI基础设施投资了极刻光核、思澈科技（已被收购）、玏芯科技；围绕AI感知投资了灵明光子、博升光电、驭光科技（已被收购）、芯感通；围绕5G基础设施投资了芯朴科技、比科奇、极芯通讯、频岢微电子；围绕第四代半导体材料投资了富加镓业。如今，灵明光子已成长为高质量dToF传感芯片和系统解决方案提供商，产品可广泛覆盖车载激光雷达及智能座舱传感系统、智能手机等多种3D传感器应用终端及场景...至于提供世界级的MCU产品及全套解决方案的思澈科技，不久前已被上市公司收购。此外，他们天使轮投的硅谷项目，也于2025年初被大厂并购。不管是被投的快速成长，亦或是项目的成功退出，关键在于联想之星对"人"和"事"的精准判断。"事为先，人为重，最重要的是人和事的匹配。"王明耀坦言，还是得看创业者适不适合做这件事，而半导体芯片行业适合精英创业。 "不管创业者具体做什么事，我们通常还是会收敛到'人'这个维度。" 高天垚补充道。以图灵量子为例。2021年4月，联想之星在这家公司天使轮融资时，果断投资了对方2500万元。虽然当时不少人认为量子计算离商业化落地很远，但联想之星却更看重对方核心团队的综合实力。在他们看来，创始人金贤敏作为上海交大量子实验室主任，不仅是学术能力强大的科学家，还是富有创业激情和商业能力极强的创业者。此外，图灵量子还拥有全球唯一同时具备"芯片制备+量子计算+光子计算+人工智能"技术的团队。目前，图灵量子已经构建了"芯片+算法"双轮驱动，打造了"自主可控技术+全链条IDM能力"，形成从技术研发到产业落地的完整闭环，同时还联合上海交大、上海交大无锡光子芯片研究院打造了中国首条光子芯片中试线。对于联想之星而言，爱芯元智上市的锣声如同一声响亮的发令枪。面对战略价值不断提高的半导体芯片行业，联想之星有望收获越来越多的半导体芯片IPO。科创投资形成新格局 联想之星迎来新篇章在投早、投小、投科技成为行业共识前，联想之星已在这条难而正确的道路上坚持多年。"由于自身独特的基因，我们会重点投资有意义、有价值、有技术含量的早期项目。"据王明耀透露，目前，联想之星作为首轮机构投资的项目比例在70%左右。在行业火热前，联想之星便已早早布局。2010年，人工智能概念尚未流行时便开始系统布局；2014年，以行业先行者的身份寻找自动驾驶项目；2015年，成为最早一批投资商业航天的机构...在可控核聚变爆火前，联想之星也已提前入局。对科创投资的长期实践与深入观察，让王明耀在2024年敏锐察觉到，新质生产力的提出开启了科创投资的新时代，"中国经济结构正从传统向创新转型，同时国资以及政府配套政策为科创投资提供了稳定的基础。"基于这个精准的前瞻性判断，联想之星以敏捷的姿态主动出击，提前加大了对科技属性显著的项目的投资力度。以人工智能为主线，他们2025年新投的十几个项目科技属性几乎都拉满了，覆盖的也是深度关注的机器人、半导体芯片、低空经济、脑机结合、新能源等方向。虽然联想之星占据先发优势，同时也积累了深厚的资源，但众多投资机构的扎堆涌入，正让中国科创投资的竞争变得愈发激烈，也给他们带来了巨大的挑战。在科创投资新格局下，联想之星给出的破局之法是一方面，对市场尚未形成共识的赛道和项目进行提前布局；另一方面，在已有共识的方向和领域投更新和投更精。"现在很多投资机构都在投早、投小、投科技，所以我们需要更往前一步进行布局。"在王明耀看来，投更新，是要在行业明确的趋势和拐点到来之前，提前对具有创新要素的项目进行预判；投更精，是要在估值上涨的前提下，通过对项目进行横向综合比较，优中选优。得益于对科创投资的深刻认知，以及在资源、人脉、团队建设等方面的长期深耕，联想之星正迎来属于自己的集中收获季。成立至今，联想之星已收获13个IPO。据王明耀透露，联想之星被投企业上市总数量很快会达到20家，"我们每一期基金的IRR都在20%以上，前三期基金DPI已回正，一期基金DPI已超过5。"优异的投资回报和规范的运营标准，也让联想之星的新一期基金募资进展超预期顺利，预计不久后将实现超募关账。除了LP复投比例超过60%，他们新一期基金还获得由国家发改委、财政部共同推动设立的国家创业投资引导基金出资，成为对方首批签约基金。按照联想之星的规划，新一期基金会重点关注AI+硬科技领域，包括具身智能、AI大模型、AI应用、AI基础设施（芯片、算力、光传输、光传感），还有低空经济、核能科技、量子信息、医疗（智能化医疗器械、创新疗法）等。放眼望去，创业投资正在成为发展新质生产力的重要引擎，同时中国创投行业正在形成新的投资范式。在这场长达十年甚至更久的科创投资大潮中，联想之星正在加速开启属于自己的新篇章。来源：联想控股微空间 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute.SAN FRANCISCO / MUMBAI, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - CleverTap, the all-in-one customer engagement platform, today announced that they have been positioned by Gartner® as a Leader in their 2026 Magic Quadrant™ for Personalization Engines.We believe this recognition underscores the progress we are making alongside our customers, a growing ecosystem of forward-looking brands and partners dedicated to delivering relevant, responsible, and effective personalization.Our approach to hyper-personalization, individualized to each customer,  is built around agentic AI capabilities from CleverAI™ designed to deliver "Experience of One” through 1:1 engagement at scale. We believe the CleverAI™ Decisioning Engine plays a central role in interpreting customer intent, enabling brands to connect customers with the right message, on the right channel, at the right moment. Combined with a comprehensive suite of personalization capabilities, we believe these capabilities are helping brands drive measurable outcomes, including up to 35% higher conversion rates across key use cases in industries like financial services, retail, ecommerce, media, telecom, and many others.At the core of this approach is CleverAI™, our enterprise-grade agentic intelligence and decisioning engine. Designed for autonomous real-time orchestration, it enables continuous experience optimization across the customer lifecycle. We believe this focus on unified intelligence, real-time decisioning, and scalable hyper-personalization has contributed to our broader market momentum.“We consider our positioning in the Leaders Quadrant by Gartner as confirmation of our capability that enables customers to improve business outcomes with the power of CleverAI™,” said Anand Jain, Co-founder and Chief Marketing Officer, CleverTap.“We continue to innovate while we execute on our product roadmap. With CleverAI™, we are delivering a truly revolutionary AI-First Customer Engagement Platform that will change the face of the martech and customer engagement industry, further enhancing our market position”.View a complimentary copy of the Magic Quadrant report to learn more about CleverTap’s strengths and cautions, among other provider offerings, here.(Gartner, “Magic Quadrant for Personalization Engines,” by Penny Gillespie, Jason Daigler, Michael Ro, Ross Cosner, 3 February 2026.)Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates.Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.About CleverTapCleverTap is the world’s leading AI-first, all-in-one customer engagement and retention platform, helping brands turn data into lasting customer relationships. Powered by its proprietary CleverAI™: Decisioning Engine and Agentic AI-verse, CleverTap enables organizations to maximize customer lifetime value at scale. Its unified platform brings together AI-powered segmentation, personalization, experimentation, journey orchestration, and deep analytics—seamlessly integrated with 100+ leading martech solutions.With backing from global investors including Accel, Peak XV Partners, Tiger Global, CDPQ, and 360 One, CleverTap has presence across  US, Europe, the Middle East, Latin America, and Asia. Leading brands such as TD Bank, Burger King, Paytm, Levi’s, IKEA, Decathlon, Vodafone, Domino’s, Jio, Carousell, Banco Azteca, Zomato, StockX, and Emirates NBD,  rely on CleverTap to drive measurable growth through meaningful customer engagement.For more information, visit clevertap.com or follow us on:LinkedIn: https://www.linkedin.com/company/clevertap/X: https://twitter.com/CleverTapForward-Looking StatementsSome of the statements in this press release may represent CleverTap's belief in connection with future events and may be forward-looking statements, or statements of future expectations based on currently available information. CleverTap cautions that such statements are naturally subject to risks and uncertainties that could result in the actual outcome being absolutely different from the results anticipated by the statements mentioned in the press release.Factors such as the development of general economic conditions affecting our business, future market conditions, our ability to maintain cost advantages, uncertainty with respect to earnings, corporate actions, client concentration, reduced demand, liability or damages in our service contracts, unusual catastrophic loss events, war, political instability, changes in government policies or laws, legal restrictions impacting our business, impact of pandemic, epidemic, any natural calamity and other factors that are naturally beyond our control, changes in the capital markets and other circumstances may cause the actual events or results to be materially different, from those anticipated by such statements. CleverTap does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated or revised status of such statements. Therefore, in no case whatsoever will CleverTap and its affiliate companies be liable to anyone for any decision made or action taken in conjunction.For more information:ADITYA SANYALDirector, Digital Marketing, CleverTap+91 9177110080aditya.sanyal@clevertap.comASHMIT CHAUDHARYAssociate Consultant, Archetype+91 8850752121ashmit.chaudhary@archetype.co Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SAN DIEGO, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA-ASI) was competitively selected by the U.S. Marine Corps (USMC) for evaluation in the Marine Air-Ground Task Force Uncrewed Expeditionary Tactical Aircraft (MUX TACAIR) Collaborative Combat Aircraft (CCA) program. The agreement integrates GA-ASI's expertise in autonomy and uncrewed aircraft systems with a government-provided mission package, usingthe YFQ-42A platform as a surrogate to evaluate integration with crewed fighters.The contract initiates integration of a Marine Corps mission kit into the YFQ-42A surrogate platform for assessment within the Marine Air Ground Task Force (MAGTF).The USMC contract includes the rapid development of autonomy for the government-supplied mission kit - a cost-effective, sensor-rich, software-defined suite capable of delivering kinetic and non-kinetic effects - positioning the solution for use in expeditionary operations. This work will support evaluations of future MUX TACAIR capabilities."This selection builds upon the GA-ASI autonomous systems in use today and demonstrates our commitment to delivering next generation capabilities for critical USMC missions," said Mike Atwood, Vice President of Advanced Programs for GA-ASI. "Our FQ-42, combined with our proven autonomy architecture and integration expertise, positions us to rapidly deliver an affordable CCA solution that enhances the Marine Air-Ground Task Force's operational effectiveness in contested environments."GA-ASI was selected by the U.S. Air Force in April 2024 to build production-representative flight test articles for the CCA program. The YFQ-42A successfully conducted its maiden flight in August 2025, validating a "genus/species" concept for rapid, modular, and low-cost uncrewed fighter aircraft development. This approach enables a common core aircraft design that can be rapidly adapted for different mission sets and service requirements.The YFQ-42A is a purpose-built CCA platform developed as part of GA-ASI's ongoing investment in next-generation autonomous combat aircraft. The aircraft's modular design enables rapid integration of mission systems. GA-ASI's autonomy architecture, demonstrated through multiple live flight tests, provides the foundation for human-machine teaming in complex combat scenarios.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.GA-ASI Media RelationsGeneral Atomics Aeronautical Systems, Inc.ASI-MediaRelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

LONDON, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - Diets high in meat, eggs, and dairy products incur significant environmental costs. But a new study has revealed that, in many cases, switching your dog to a more sustainable diet may have a bigger impact on the planet and farmed animals than changing your own diet.The research, published in the journal Animals by veterinary Professor Andrew Knight, found that the average dog consumes around 13 farmed land animals annually within its diet, compared with nine for the average person--a difference of roughly 40%. This gap exists largely because a greater proportion of a typical dog's dietary energy comes from animal-based ingredients--about 34%--compared to around 19% for people.These figures represent global averages and vary by country. In high-income nations such as the United States, consumption is higher across the board. There, an average person consumes 24 farmed land animals annually, compared with 20 for a dog--a smaller difference of about 20%.Traditional meat-based pet foods therefore have substantial environmental and animal welfare impacts. However, alternatives based on plants, microbial protein, and cultivated meat are becoming more widely available. Fully plant-based, or vegan, pet foods can now be easily purchased from online retailers in many countries. By early 2026, 14 studies and one systematic review had reported good health outcomes for dogs or cats fed such diets. However, pet diets should be produced by responsible manufacturers and fully supplemented to ensure all necessary nutrients are included.The potential benefits are substantial. If all pet dogs switched to nutritionally sound vegan diets, six billion land animals could be spared from slaughter each year. Greenhouse gas savings would be 1.5 times the UK's annual emissions, and the food energy conserved could feed 450 million people--the population of the European Union. These calculations are based on 2018 data, and with dog populations growing faster than human populations, the potential benefits are even greater today.After analysing survey responses from thousands of pet carers, Knight also estimated that at least 150 million dogs and cats could realistically be transitioned to nutritionally sound vegan diets. However, because the analysis assumed only one dog or cat per household, he noted that the true numbers are probably several times higher.The study evaluated sustainable pet diets using the principles of effective altruism, a philosophy that prioritises issues based on scale, neglect, and solvability, in order to maximise benefits. It found sustainable pet diets to be highly neglected, with only about two full-time researchers worldwide outside pet food companies, and less than one percent of the farmed animal advocacy movement's annual budget devoted to it.Knight concluded that plant-based pet diets represent a powerful but overlooked way to reduce farmed animal use, improve food security, and address climate and biodiversity challenges. He urged animal and environmental advocates to look beyond a solely human-focused approach to more sustainable diets. "It's ironic", he said, "that the animal advocacy movement has largely overlooked the diets of its own companion animals."Prof. Andrew Knighta.knight@griffith.edu.auSOURCE: Sustainable Pet Food Foundation Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, Feb 11, 2026 - (ACN Newswire via SeaPRwire.com) - Asia’s longest-running sustainability event is coming to Bangkok. On 23 April 2026, the 18th Annual Global CSR & ESG Summit & Awards 2026 lands in Thailand’s vibrant capital, bringing together global leaders, innovators, and changemakers for a high-energy, future-focused gathering that redefines what a sustainability summit can be.Guided by the theme “AI, Energy & Transition: Resetting ESG in a New Economy,” this flagship Summit reimagines the traditional conference into an immersive, high-impact experience—bringing together innovation, leadership, and purpose on one dynamic stage.More than a conference, the Summit combines visionary discussions with inspiring award moments, exploring sustainability in an era shaped by AI, energy transition, and geopolitical change. Through immersive presentations, thought-provoking panels, and four integrated award segments, participants will examine how these forces are reshaping corporate responsibility—and whether ESG is evolving fast enough for a digitised, energy-hungry world.The refreshed format blends insight with inspiration, featuring cinematic storytelling, live performances, and real-world case studies that spotlight purpose-driven leadership and transformational impact.With over 60 companies already confirmed from across Asia and beyond, momentum is strong.Organisations are also invited to participate in the 18th Annual Global CSR & ESG Awards™️ 2026, recognising initiatives that demonstrate measurable impact, strong governance, and strategic foresight.Award Categories Include:- Best Environmental Excellence Award- Best Community Programme Award- Excellence in Provision of Literacy & Education Award- Empowerment of Women Award- Best Workplace Practices- Product Excellence Award- CSR & ESG Leadership Award- Best CEO | Best CFO- Best Corporate Communications & Investor Relations TeamBest Country Awards: Singapore | Malaysia | Thailand | Philippines | India | Indonesia | Cambodia | Vietnam | Middle EastAs ESG expectations rise, the Summit offers a timely platform for meaningful dialogue, practical insights, and recognition of credible initiatives—set against the vibrant backdrop of Bangkok.Join us to ignite action, celebrate excellence, and help redefine ESG for a rapidly changing global economy.For more information visit the official Website: https://globalcsr.pinnaclegroup.global/For Media Inquiries:Eric KhooConference Director18th Annual Global CSR & ESG Summit & Awards™️eric.khoo@pinnaclegroup.globalHDP / WhatsApp: +65 8383 2480 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

加利福尼亚州圣地亚哥市, 2026年2月11日 - (亚太商讯 via SeaPRwire.com) - 通用原子航空系统公司（GA-ASI）在竞争中获美国海军陆战队（USMC）选定，参与海军陆战队空地特遣部队无人远征战术飞机（MUX TACAIR）协同作战飞机（CCA）项目的评估。该协议将GA-ASI在自主飞行与无人飞行器系统领域的专长与政府提供的任务套件相结合，采用YFQ-42A平台作为替代机型，评估其与有人战斗机的集成能力。合同启动了将海军陆战队任务套件集成至YFQ-42A替代平台的工作，以便在海军陆战队空地特遣部队（MAGTF）框架内进行评估。该海军陆战队合同包含对政府提供的任务套件进行快速自主化开发——该套件作为经济高效、传感器密集、软件定义的系统，可实施动能与非动能打击，旨在为远征作战部署解决方案。此项工作将为未来MUX TACAIR能力的评估提供支持。通用原子航空系统公司先进项目副总裁迈克·阿特伍德表示：“此次选型基于现役GA-ASI自主系统，彰显了我们为海军陆战队关键任务提供新一代能力的承诺。凭借成熟的自主架构与集成技术，我们的FQ-42系统将助力快速交付经济高效的近程空中防御解决方案，显著提升海军陆战队空地特遣部队在对抗环境中的作战效能。”2024年4月，美国空军选定GA-ASI为CCA项目制造具有量产代表性的飞行测试样机。YFQ-42A于2025年8月成功完成首飞，验证了快速、模块化、低成本无人战斗机开发的“通用平台/专用型号”理念。该方案通过通用核心机体设计，可快速适配不同任务需求与军种要求。YFQ-42A是一款专为近距空中作战（CCA）打造的平台，作为通用原子航空系统公司（GA-ASI）持续投资下一代自主作战飞机计划的重要组成部分而研发。该机采用模块化设计，可快速集成任务系统。GA-ASI的自主架构已通过多次实机飞行测试验证，为复杂作战场景中的人机协同作战奠定了基础。关于通用原子航空系统公司通用原子航空系统公司是全球领先的无人机系统制造商。捕食者®系列无人机累计飞行时长逾900万小时，服役超过30年，涵盖MQ-9A死神®、MQ-1C灰鹰®、MQ-20复仇者®及MQ-9B天卫者®/海卫者®机型。公司致力于提供长航时多任务解决方案，实现持续态势感知与快速打击能力。欲了解更多信息，请访问 www.ga-asi.com 。Avenger、EagleEye、Gray Eagle、Lynx、Predator、Reaper、SeaGuardian 和 SkyGuardian 是通用原子航空系统公司（General Atomics Aeronautical Systems, Inc.）在美国及其他国家/地区注册的商标。GA-ASI 媒体关系部通用原子航空系统公司ASI-MediaRelations@ga-asi.com (858) 524-8101来源：通用原子航空系统公司 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

英国伦敦, 2026年2月11日 - (亚太商讯 via SeaPRwire.com) - 高肉类、蛋类和乳制品的饮食会造成显著的环境成本。但最新研究揭示，在许多情况下，将爱犬的饮食调整为更可持续的方案，对地球环境和养殖动物产生的积极影响可能远大于改变人类自身饮食。兽医教授安德鲁·奈特在《动物》期刊发表的研究发现，平均每只狗每年饮食中消耗约13只农场陆生动物，而人类仅消耗9只——差距约达40%。这种差异主要源于犬类饮食中动物性成分占比更高（约34%），而人类饮食中该比例仅为19%。这些数据为全球平均值，各国存在差异。在美国等高收入国家，整体消耗量更高：当地人均年消耗24只养殖陆生动物，而犬类仅消耗20只，差距缩小至约20%。传统肉类宠物食品因此对环境和动物福利造成显著影响。然而，基于植物、微生物蛋白和培养肉的替代品正日益普及。如今在许多国家，纯植物（纯素）宠物食品已可通过线上零售商轻松购得。截至2026年初，已有14项研究和1项系统综述证实v，采用此类饮食的犬猫健康状况良好。但宠物食品必须由负责任的制造商生产，并全面补充营养以确保涵盖所有必需营养素。潜在效益极为可观。若全球宠物犬全面转为营养均衡的纯素饮食，每年可避免60亿陆生动物被宰杀。温室气体减排量将达英国年排放量的1.5倍，节省的粮食能量足以养活4.5亿人口——相当于欧盟总人口规模。这些数据基于2018年统计，鉴于犬类数量增长速度超过人类，当前潜在效益更为显著。通过分析数千名宠物饲养者的调查反馈，奈特还估算至少1.5亿只猫狗可切实转型为营养均衡的纯素饮食。但他指出，由于分析假设每户仅饲养一只宠物，实际数量可能高出数倍。该研究运用有效利他主义原则评估可持续宠物饮食方案——该哲学体系依据规模、忽视程度及可解决性对议题进行优先级排序，以实现效益最大化。研究发现可持续宠物饮食领域存在严重忽视：全球仅有约两名非宠物食品公司的全职研究者，且养殖动物权益运动年度预算中投入该领域的比例不足1%。奈特总结指出，植物性宠物饮食是减少养殖动物使用、改善粮食安全、应对气候与生物多样性挑战的强有力却被忽视的途径。他敦促动物与环境倡导者突破仅关注人类饮食的局限，探索更可持续的饮食模式。“颇具讽刺意味的是，”他坦言，“动物权益运动却普遍忽视了自身伴侣动物的饮食问题。”安德鲁·奈特教授a.knight@griffith.edu.au 来源：可持续宠物食品基金会 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com